- Home
- FENC vs WHG Comparison
FENC vs WHG Comparison
Compare FENC & WHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- WHG
- Stock Information
- Founded
- FENC 1996
- WHG 1983
- Country
- FENC United States
- WHG United States
- Employees
- FENC N/A
- WHG N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- WHG Investment Managers
- Sector
- FENC Health Care
- WHG Finance
- Exchange
- FENC Nasdaq
- WHG Nasdaq
- Market Cap
- FENC 156.9M
- WHG 141.9M
- IPO Year
- FENC 2001
- WHG 2002
- Fundamental
- Price
- FENC $6.65
- WHG $16.44
- Analyst Decision
- FENC Strong Buy
- WHG
- Analyst Count
- FENC 2
- WHG 0
- Target Price
- FENC $14.00
- WHG N/A
- AVG Volume (30 Days)
- FENC 53.9K
- WHG 14.1K
- Earning Date
- FENC 03-20-2025
- WHG 02-12-2025
- Dividend Yield
- FENC N/A
- WHG 3.57%
- EPS Growth
- FENC N/A
- WHG N/A
- EPS
- FENC N/A
- WHG 0.26
- Revenue
- FENC $49,348,000.00
- WHG $94,721,000.00
- Revenue This Year
- FENC $170.43
- WHG N/A
- Revenue Next Year
- FENC $6.70
- WHG N/A
- P/E Ratio
- FENC N/A
- WHG $65.73
- Revenue Growth
- FENC 278.09
- WHG 5.50
- 52 Week Low
- FENC $3.96
- WHG $11.01
- 52 Week High
- FENC $11.49
- WHG $18.03
- Technical
- Relative Strength Index (RSI)
- FENC 58.24
- WHG 56.90
- Support Level
- FENC $6.57
- WHG $16.41
- Resistance Level
- FENC $6.96
- WHG $17.24
- Average True Range (ATR)
- FENC 0.26
- WHG 0.75
- MACD
- FENC -0.02
- WHG 0.12
- Stochastic Oscillator
- FENC 61.25
- WHG 67.14
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About WHG Westwood Holdings Group Inc
Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals, and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high-net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States.